Mechanistic studies demonstrated that PRMT5 could epigenetically suppress FBW7 expression and elevate cMyc stability, leading to tumorigenicity and aerobic glycolysis in pancreatic cancer. This evidence concerns the gene FBXW7 and pancreatic neoplasm.